Kelly, Andrea
Philadelphia, PA, Pittsburgh, PA
5 papers on CoChatORCID 0000-0003-1724-9868
Most cited papers
- Verified
ISPAD Clinical Practice Consensus Guidelines 2022: Management of cystic fibrosis‐related diabetes in children and adolescents
Ode, K. L., Ballman, M., Battezzati, A., Brennan, A., Chan, C. L., Hameed, S., Ismail, H. M., Kelly, A., Moran, A. M., Rabasa‐Lhoret, R., et al. (2022) · Pediatric Diabetes
Cystic Fibrosis Research AdvancesDiabetes Management and Research
Cited by 95
- Verified
Catecholamines, adiponectin, and insulin resistance as measured by HOMA in children with obstructive sleep apnea
Kelly, A., Dougherty, S., Cucchiara, A., Marcus, C. L., & Brooks, L. J. (2010) · SLEEP
Obstructive Sleep Apnea ResearchAdipokines, Inflammation, and Metabolic Diseases
Cited by 85
- Verified
Acarbose treatment of postprandial hypoglycemia in children after Nissen fundoplication
Ng, D. D., Ferry, R. J., Kelly, A., Weinzimer, S. A., Stanley, C. A., & Katz, L. E. L. (2001) · The Journal of Pediatrics
Gastroesophageal reflux and treatmentsGastrointestinal motility and disorders
Cited by 53
- Verified
Cystic Fibrosis-Related Diabetes Workshop: research priorities spanning disease pathophysiology, diagnosis, and outcomes
Putman, M. S., Norris, A. W., Hull, R. L., Rickels, M. R., Sussel, L., Blackman, S. M., Chan, C. L., Ode, K. L., Daley, T., Stecenko, A. A., et al. (2023) · Diabetes Care
Cystic Fibrosis Research AdvancesPancreatic function and diabetes
Cited by 35
- Verified
1163-P: Disparities in Glucagon-Like Peptide 1 Receptor Agonist (GLP-1RA) Utilization in Pediatric Type 2 Diabetes (T2D)
CHU, P. Y., KELLY, A., VAJRAVELU, M. E., HENNESSY, S., & AMARAL, S. (2025) · Diabetes
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 1
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free